Braveheart Bio seeks $319M in IPO backed by a16z, signaling VC firm’s expanding appetite beyond crypto
Posted On July 30, 2026
Andreessen Horowitz’s biotech investment signals a strategic shift, highlighting evolving VC priorities and potential sectoral realignments.
The post Braveheart Bio seeks $319M in IPO backed by a16z, signaling VC firm’s expanding appetite beyond crypto appeared first on Crypto Briefing.
About The Author
